We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$154M
AUM Growth
-$90.8M
Cap. Flow
-$89.2M
Cap. Flow %
-57.92%
Top 10 Hldgs %
20.11%
Holding
827
New
297
Increased
13
Reduced
39
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 21.13%
2 Technology 16.45%
3 Healthcare 14.29%
4 Industrials 11.13%
5 Consumer Discretionary 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITC icon
676
SITE Centers
SITC
$236M
-3,003
Closed -$45.9K
SKT icon
677
Tanger
SKT
$4.78B
-5,542
Closed -$189K
SLN
678
Silence Therapeutics
SLN
$546M
-10,772
Closed -$74.1K
SLNO
679
DELISTED
Soleno Therapeutics
SLNO
-1,536
Closed -$69K
SLRN
680
DELISTED
ACELYRIN
SLRN
-20,083
Closed -$63.1K
SLRC icon
681
SLR Investment Corp
SLRC
$704M
-51,000
Closed -$824K
SMCI icon
682
Super Micro Computer
SMCI
$16.6B
-24,112
Closed -$735K
SMMT icon
683
Summit Therapeutics
SMMT
$10.2B
-3,979
Closed -$71K
SNDX icon
684
Syndax Pharmaceuticals
SNDX
$1.7B
-5,278
Closed -$69.8K
SPOK icon
685
Spok Holdings
SPOK
$229M
-11,643
Closed -$187K
SPOT icon
686
Spotify
SPOT
$108B
-2,991
Closed -$1.34M
SRPT icon
687
Sarepta Therapeutics
SRPT
$1.64B
-2,809
Closed -$342K
SRRK icon
688
Scholar Rock
SRRK
$5.88B
-1,707
Closed -$73.8K
STOK icon
689
Stoke Therapeutics
STOK
$1.84B
-5,770
Closed -$63.6K
STR
690
DELISTED
Sitio Royalties
STR
-8,124
Closed -$156K
SVRA icon
691
Savara
SVRA
$1.08B
-21,222
Closed -$65.2K
SWTX
692
DELISTED
SpringWorks Therapeutics
SWTX
-9,037
Closed -$327K
SYK icon
693
Stryker
SYK
$135B
-3,228
Closed -$1.16M
SYRE icon
694
Spyre Therapeutics
SYRE
$8.5B
-2,972
Closed -$69.2K
TARS icon
695
Tarsus Pharmaceuticals
TARS
$2.55B
-6,845
Closed -$379K
TBPH icon
696
Theravance Biopharma
TBPH
$873M
-35,426
Closed -$333K
TCPC icon
697
BlackRock TCP Capital
TCPC
$278M
-132,795
Closed -$1.16M
TEL icon
698
TE Connectivity
TEL
$60B
-7,627
Closed -$1.09M
TERN
699
DELISTED
Terns Pharmaceuticals
TERN
-10,788
Closed -$59.8K
TGTX icon
700
TG Therapeutics
TGTX
$8.19B
-11,393
Closed -$343K

Similar funds

Virtus ETF Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus ETF Advisers held 827 positions worth $154M, down 37% from $245M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Virtus ETF Advisers withdrew a net $89.2M in Q1 2025, closing 409 positions and reducing 39 holdings. Its most notable exit was OFS Credit Co, an estimated $2.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in ICICI Bank worth $8.23M.

  • Virtus ETF Advisers's largest Q1 2025 buy was ICICI Bank: 261,046 shares worth $8.23M.
  • Virtus ETF Advisers added most to Microsoft in Q1 2025, an estimated $1.1M increase.
  • Virtus ETF Advisers's biggest Q1 2025 reduction was Fortinet, cutting an estimated $1.33M.
  • Virtus ETF Advisers fully exited OFS Credit Co in Q1 2025, selling an estimated $2.26M.
  • Virtus ETF Advisers's ten largest holdings make up 20% of its $154M portfolio in Q1 2025.
  • Virtus ETF Advisers opened 297 new positions and closed 409 in Q1 2025.
  • Virtus ETF Advisers's portfolio value fell 37% quarter-over-quarter to $154M.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.